83_FR_12454 83 FR 12399 - Office of The Director, National Institutes of Health; Notice of Meeting

83 FR 12399 - Office of The Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 55 (March 21, 2018)

Page Range12399-12399
FR Document2018-05740

Federal Register, Volume 83 Issue 55 (Wednesday, March 21, 2018)
[Federal Register Volume 83, Number 55 (Wednesday, March 21, 2018)]
[Notices]
[Page 12399]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-05740]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of The Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Advisory Committee 
to the Director, National Institutes of Health.
    The meeting will be held as a teleconference call only and is open 
to the public to dial-in for participation. Individuals who plan to 
dial-in to the meeting and need special assistance or other reasonable 
accommodations in order to do so, should notify the Contact Person 
listed below in advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National 
Institutes of Health.
    Date: April 6, 2018.
    Time: 4:00 p.m. to 5:30 p.m.
    Agenda: Report from the Working Group on Ethical Consideration 
for Industry Partnership on Research to Help End the Opioid Crisis.
    Place: National Institutes of Health, Building 1, One Center 
Drive, Bethesda, MD 20892 (Telephone Conference Call), 888-324-9616, 
Access Code: 1986191.
    Contact Person: Gretchen Wood, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: http://acd.od.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: March 16, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-05740 Filed 3-20-18; 8:45 am]
 BILLING CODE 4140-01-P



                                                                            Federal Register / Vol. 83, No. 55 / Wednesday, March 21, 2018 / Notices                                                  12399

                                                Guidances/default.htm, https://                         Immunodeficiency Syndrome Research Loan               National Cancer Institute, NIH, 9609 Medical
                                                www.fda.gov/BiologicsBloodVaccines/                     Repayment Program; 93.187, Undergraduate              Center Drive, Room 7W264, Bethesda, MD
                                                GuidanceComplianceRegulatory                            Scholarship Program for Individuals from              20892–9750, 240–276–7286, salvucco@
                                                                                                        Disadvantaged Backgrounds, National                   mail.nih.gov.
                                                Information/Guidances/default.htm, or
                                                                                                        Institutes of Health, HHS)                            (Catalogue of Federal Domestic Assistance
                                                https://www.regulations.gov.
                                                                                                          Dated: March 16, 2018.                              Program Nos. 93.392, Cancer Construction;
                                                  Dated: March 15, 2018.                                                                                      93.393, Cancer Cause and Prevention
                                                                                                        Natasha M. Copeland,
                                                Leslie Kux,                                                                                                   Research; 93.394, Cancer Detection and
                                                                                                        Program Analyst, Office of Federal Advisory           Diagnosis Research; 93.395, Cancer
                                                Associate Commissioner for Policy.
                                                                                                        Committee Policy.                                     Treatment Research; 93.396, Cancer Biology
                                                [FR Doc. 2018–05659 Filed 3–20–18; 8:45 am]
                                                                                                        [FR Doc. 2018–05740 Filed 3–20–18; 8:45 am]           Research; 93.397, Cancer Centers Support;
                                                BILLING CODE 4164–01–P
                                                                                                        BILLING CODE 4140–01–P                                93.398, Cancer Research Manpower; 93.399,
                                                                                                                                                              Cancer Control, National Institutes of Health,
                                                                                                                                                              HHS)
                                                DEPARTMENT OF HEALTH AND
                                                                                                        DEPARTMENT OF HEALTH AND                                Dated: March 16, 2018.
                                                HUMAN SERVICES
                                                                                                        HUMAN SERVICES                                        Melanie J. Pantoja,
                                                National Institutes of Health                                                                                 Program Analyst, Office of Federal Advisory
                                                                                                        National Institutes of Health
                                                                                                                                                              Committee Policy.
                                                Office of The Director, National                                                                              [FR Doc. 2018–05737 Filed 3–20–18; 8:45 am]
                                                                                                        National Cancer Institute; Notice of
                                                Institutes of Health; Notice of Meeting
                                                                                                        Closed Meetings                                       BILLING CODE 4140–01–P
                                                   Pursuant to section 10(d) of the
                                                                                                          Pursuant to section 10(d) of the
                                                Federal Advisory Committee Act, as
                                                                                                        Federal Advisory Committee Act, as                    DEPARTMENT OF HEALTH AND
                                                amended, notice is hereby given of a
                                                                                                        amended, notice is hereby given of the                HUMAN SERVICES
                                                meeting of the Advisory Committee to
                                                                                                        following meetings.
                                                the Director, National Institutes of                      The meetings will be closed to the                  National Institutes of Health
                                                Health.                                                 public in accordance with the
                                                   The meeting will be held as a                                                                              National Center for Advancing
                                                                                                        provisions set forth in sections
                                                teleconference call only and is open to                                                                       Translational Sciences; Notice of
                                                                                                        552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                the public to dial-in for participation.                                                                      Meetings
                                                                                                        as amended. The grant applications and
                                                Individuals who plan to dial-in to the
                                                                                                        the discussions could disclose
                                                meeting and need special assistance or                                                                           Pursuant to section 10(d) of the
                                                                                                        confidential trade secrets or commercial
                                                other reasonable accommodations in                                                                            Federal Advisory Committee Act, as
                                                                                                        property such as patentable material,
                                                order to do so, should notify the Contact                                                                     amended, notice is hereby given of
                                                                                                        and personal information concerning
                                                Person listed below in advance of the                                                                         meetings of the National Center for
                                                                                                        individuals associated with grant
                                                meeting.                                                                                                      Advancing Translational Sciences.
                                                                                                        applications, the disclosure of which
                                                   Name of Committee: Advisory Committee                would constitute a clearly unwarranted                   The meetings will be open to the
                                                to the Director, National Institutes of Health.         invasion of personal privacy.                         public as indicated below, with
                                                   Date: April 6, 2018.                                                                                       attendance limited to space available.
                                                   Time: 4:00 p.m. to 5:30 p.m.                           Name of Committee: National Cancer
                                                                                                        Institute Special Emphasis Panel;                     Individuals who plan to attend and
                                                   Agenda: Report from the Working Group
                                                on Ethical Consideration for Industry                   Approaches to Identify and Care for                   need special assistance, such as sign
                                                Partnership on Research to Help End the                 Individuals with Inherited Cancer                     language interpretation or other
                                                Opioid Crisis.                                          Syndromes.                                            reasonable accommodations, should
                                                   Place: National Institutes of Health,                  Date: April 26, 2018.                               notify the Contact Person listed below
                                                Building 1, One Center Drive, Bethesda, MD                Time: 11:00 a.m. to 3:00 p.m.                       in advance of the meeting.
                                                20892 (Telephone Conference Call), 888–                   Agenda: To review and evaluate grant                   The meetings will be closed to the
                                                324–9616, Access Code: 1986191.                         applications.
                                                   Contact Person: Gretchen Wood, Staff                   Place: National Cancer Institute, Shady
                                                                                                                                                              public in accordance with the
                                                Assistant, National Institutes of Health,               Grove, 9609 Medical Center Drive, Room                provisions set forth in sections
                                                Office of the Director, One Center Drive,               7W640 Rockville, MD 20850 (Telephone                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                Building 1, Room 126, Bethesda, MD 20892,               Conference Call).                                     as amended. The grant applications and
                                                301–496–4272, Woodgs@od.nih.gov.                          Contact Person: Saejeong J. Kim, Ph.D.,             the discussions could disclose
                                                   Any interested person may file written               Scientific Review Officer, Special Review             confidential trade secrets or commercial
                                                comments with the committee by forwarding               Branch, Division of Extramural Activities,            property such as patentable material,
                                                the statement to the Contact Person listed on           National Cancer Institute, NIH, 9609 Medical          and personal information concerning
                                                this notice. The statement should include the           Center Drive, Room 7W640, Bethesda, MD                individuals associated with the grant
                                                name, address, telephone number and when                20892–9750, 240–276–5179, saejeong.kim@
                                                                                                        nih.gov.
                                                                                                                                                              applications, the disclosure of which
                                                applicable, the business or professional
                                                affiliation of the interested person.
                                                                                                                                                              would constitute a clearly unwarranted
                                                                                                          Name of Committee: National Cancer
                                                   Information is also available on the                 Institute Special Emphasis Panel; SEP–3: NCI
                                                                                                                                                              invasion of personal privacy.
                                                Institute’s/Center’s home page: http://                 Clinical and Translational Exploratory/                 Name of Committee: Cures Acceleration
                                                acd.od.nih.gov, where an agenda and any                 Developmental Studies.                                Network Review Board.
                                                additional information for the meeting will               Date: June 5–6, 2018.                                 Date: May 10, 2018.
                                                be posted when available.                                 Time: 4:00 p.m. to 5:00 p.m.                          Time: 8:30 a.m. to 3:00 p.m.
sradovich on DSK3GMQ082PROD with NOTICES




                                                (Catalogue of Federal Domestic Assistance                 Agenda: To review and evaluate grant                  Agenda: Report from the Institute Director.
                                                Program Nos. 93.14, Intramural Research                 applications.                                           Place: National Institutes of Health,
                                                Training Award; 93.22, Clinical Research                  Place: Bethesda North Marriott Hotel &              Building 31, Conference Room 10, 31 Center
                                                Loan Repayment Program for Individuals                  Conference Center, 5701 Marinelli Road,               Drive, Bethesda, MD 20892.
                                                from Disadvantaged Backgrounds; 93.232,                 North Bethesda, MD 20852.                               Contact Person: Anna L. Ramsey-Ewing,
                                                Loan Repayment Program for Research                       Contact Person: Ombretta Salvucci, Ph.D.,           Ph.D., Executive Secretary, National Center
                                                Generally; 93.39, Academic Research                     Scientific Review Officer, Special Review             for Advancing Translational Sciences, 1
                                                Enhancement Award; 93.936, NIH Acquired                 Branch, Division of Extramural Activities,            Democracy Plaza, Room 1072, Bethesda, MD



                                           VerDate Sep<11>2014   18:34 Mar 20, 2018   Jkt 244001   PO 00000   Frm 00067   Fmt 4703   Sfmt 4703   E:\FR\FM\21MRN1.SGM   21MRN1



Document Created: 2018-03-21 00:45:43
Document Modified: 2018-03-21 00:45:43
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 6, 2018.
FR Citation83 FR 12399 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR